CV Sciences, Inc.
CVSI
$0.03
$0.006.15%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.86% | -15.76% | -8.45% | -9.90% | 2.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.86% | -15.76% | -8.45% | -9.90% | 2.18% |
| Cost of Revenue | -25.87% | -19.65% | -15.19% | -9.35% | 7.19% |
| Gross Profit | -0.36% | -11.19% | -0.86% | -10.52% | -3.73% |
| SG&A Expenses | -15.91% | -17.19% | -1.33% | -12.23% | -12.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.11% | -18.38% | -7.91% | -22.22% | -3.42% |
| Operating Income | 81.39% | 40.35% | -10.08% | 101.77% | 36.83% |
| Income Before Tax | 72.43% | 16.23% | 55.31% | 83.60% | 15.72% |
| Income Tax Expenses | 114.29% | -- | -- | 16.67% | -55.56% |
| Earnings from Continuing Operations | 71.63% | 16.23% | 55.31% | 82.64% | 16.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.63% | 16.23% | 55.31% | 82.64% | 16.46% |
| EBIT | 81.39% | 40.35% | -10.08% | 101.77% | 36.83% |
| EBITDA | 81.31% | 35.79% | -69.77% | 116.70% | 50.09% |
| EPS Basic | 71.79% | 16.00% | 58.82% | 84.62% | 30.36% |
| Normalized Basic EPS | 58.82% | 35.00% | -125.00% | 79.17% | 32.00% |
| EPS Diluted | -79.49% | 16.00% | 58.82% | 84.62% | 31.58% |
| Normalized Diluted EPS | 58.82% | 35.00% | -125.00% | 79.17% | 32.00% |
| Average Basic Shares Outstanding | -0.03% | 1.10% | 6.87% | 12.99% | 17.80% |
| Average Diluted Shares Outstanding | -0.03% | 1.10% | 6.87% | 12.99% | 17.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |